Verona Pharma plc (VRP.L) (LON:VRP) Stock Price Passes Above 200-Day Moving Average of $55.00

Verona Pharma plc (VRP.L) (LON:VRP) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 55 ($0.68) and traded as high as GBX 56 ($0.70). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.68), with a volume of 70,791 shares trading hands.

Verona Pharma plc (VRP.L) Stock Performance

The firm has a market cap of £228.00 million and a P/E ratio of -1.68. The company has a debt-to-equity ratio of 6.85, a current ratio of 2.99 and a quick ratio of 2.47. The stock’s 50 day moving average is GBX 55 and its two-hundred day moving average is GBX 55.

Verona Pharma plc (VRP.L) Company Profile

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.